Source: European Medicines Agency (EU) Revision Year: 2018 Publisher: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ, Utrecht, The Netherlands
Humalog Mix50 100 units/ml, suspension for injection in cartridge.
Humalog Mix50 100 units/ml KwikPen, suspension for injection in a pre-filled pen.
| Pharmaceutical Form |
|---|
|
Suspension for injection. White suspension. |
Each ml contains 100 units insulin lispro* (equivalent to 3.5mg).
Humalog Mix50 consists of 50% insulin lispro solution and 50% insulin lispro protamine suspension.
Cartridge: Each cartridge contains 300 units of insulin lispro in 3 ml suspension.
KwikPen: Each pre-filled pen contains 300 units of insulin lispro in 3 ml suspension. Each KwikPen delivers 1-60 units in steps of 1 unit.
* produced in E.coli by recombinant DNA technology.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Insulin lispro |
The primary activity of insulin lispro is the regulation of glucose metabolism. |
| List of Excipients |
|---|
|
Protamine sulphate |
The suspension is contained in type I flint glass cartridges, sealed with butyl or halobutyl disc seals and plunger heads and secured with aluminium seals. Dimeticone or silicone emulsion may have been used to treat the cartridge plunger, and/or the glass cartridge.
3 ml Cartridge: Packs of 5 or 10. Not all packs may be marketed.
The suspension is contained in type I flint glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals. Dimeticone or silicone emulsion may have been used to treat the cartridge plunger, and/or the glass cartridge. The 3 ml cartridges are sealed in a disposable pen injector, called the “KwikPen”. Needles are not included.
3 ml KwikPen: Packs of 5 or a multipack of 10 (2 packs of 5). Not all packs may be marketed.
Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ, Utrecht, The Netherlands
EU/1/96/007/006
EU/1/96/007/025
EU/1/96/007/035
EU/1/96/007/036
Date of first authorisation: 30th April 1996
Date of last renewal: 30th April 2006
| Drug | Countries | |
|---|---|---|
| HUMALOG | Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
